Uthaug M, Davis A, Haas T, Davis D, Dolan S, Lancelotta R
J Psychopharmacol. 2021; 36(3):309-320.
PMID: 33949246
PMC: 8902264.
DOI: 10.1177/02698811211013583.
Halberstadt A, Chatha M, Chapman S, Brandt S
J Psychopharmacol. 2019; 33(3):406-414.
PMID: 30789291
PMC: 6848748.
DOI: 10.1177/0269881119826610.
Kovacic P, Somanathan R
Oxid Med Cell Longev. 2010; 2(4):181-90.
PMID: 20716904
PMC: 2763256.
DOI: 10.4161/oxim.2.4.9380.
Hollister L, Macnicol M, GILLESPIE H
Psychopharmacologia. 1969; 14(1):62-73.
PMID: 5351858
DOI: 10.1007/BF00401535.
Dittrich A
Psychopharmacologia. 1971; 21(3):229-37.
PMID: 5095413
DOI: 10.1007/BF00403861.
Macromerine, normacromerine and bisnormacromerine: non-psychoactive methylated derivatives of norepinephrine.
Vogel W, Evans B, Bonnem E, Fischer J, McLaughlin J
Psychopharmacologia. 1973; 30(2):145-51.
PMID: 4711372
DOI: 10.1007/BF00421429.
Stimulus properties of mescaline and N-methylated derivatives: difference in peripheral and direct central administration.
Browne R, Harris R, Ho B
Psychopharmacologia. 1974; 39(1):43-56.
PMID: 4425137
DOI: 10.1007/BF00421457.
Autoradiographic studies on the distribution of 3H-2,3,4-trimethoxy-beta-phenylethylamine in the mouse.
Korr H, Seiler N
Psychopharmacologia. 1976; 46(1):53-8.
PMID: 1257367
DOI: 10.1007/BF00421549.
Screening hallucinogenic drugs: systematic study of three behavioral tests.
Silva M, Calil H
Psychopharmacologia. 1975; 42(2):163-71.
PMID: 1080571
DOI: 10.1007/BF00429548.
Screening hallucinogenic drugs II. Systematic study of two behavioral tests.
Calil H
Psychopharmacology (Berl). 1978; 56(1):87-92.
PMID: 415331
DOI: 10.1007/BF00571414.
Blockage of LSD binding at its high affinity site on synaptosomal membranes by 1-methyl-1,2,5,6-tetrahydropyridine-N,N-diethyl- carboxamide.
Christian S, McClain L, Morin R, Benington F
Experientia. 1975; 31(8):910-11.
PMID: 125655
DOI: 10.1007/BF02358845.
